New Jersey collaborating physician requirements underwent the most consequential change in the state’s history of APRN regulation in early 2026. For nearly six years, COVID-era emergency waivers had allowed New Jersey APNs to prescribe without joint protocols. When those waivers ended and legislative action followed, New Jersey emerged with a dual-track system that permanently changes how physician collaboration works in the state. S2996/A4052, signed March 30, 2026, creates a class of qualifying APNs who can practice and prescribe independently while preserving the joint protocol requirement for all others.
For physicians in New Jersey, this means two distinct collaboration landscapes now operate simultaneously. APNs who do not qualify for the new exemption, or who practice outside the covered care settings, still require a written joint protocol under NJSA 45:11-49 and NJAC 13:37-8.1. This guide covers the full framework physicians need to understand in 2026, including the current state of the exemption, the substantive joint protocol requirements for non-exempt APNs, and the PA delegation obligations that apply separately.
New Jersey Collaborating Physician Overview: Where New Jersey Stands
New Jersey is classified by the AANP as a reduced-practice state for APNs who do not qualify for the new S2996/A4052 exemption. The joint protocol requirement under NJSA 45:11-49 represents a career-long collaboration obligation for non-exempt APNs. For those who do qualify for the exemption, independent practice is now permanent under New Jersey law.
Governing Bodies
Two regulatory bodies govern APN-physician collaboration in New Jersey:
- New Jersey Board of Nursing: Governs APN licensure, joint protocol standards, prescriptive authority requirements, and disciplinary oversight under NJSA 45:11-47 through 45:11-56 and NJAC 13:37.
- New Jersey State Board of Medical Examiners: Governs physician licensure, physician conduct in joint protocol arrangements, and disciplinary oversight. Failure to establish and implement joint protocols consistent with board standards may be deemed professional misconduct under NJSA 45:1-21.
The 2026 Legislative Overhaul: S2996/A4052 and the New Dual-Track System
S2996/A4052, signed by Governor Mikie Sherrill on March 30, 2026, permanently restructured APN practice in New Jersey. The legislation makes independent practice available to qualifying APNs and creates a two-track system that now governs every APN in the state.
The Legislative Context
Before S2996/A4052, New Jersey operated under two layers of emergency provisions. The COVID-19 State of Emergency Executive Orders had suspended the joint protocol requirement since 2020. Former Governor Murphy issued EO 415 in late 2025 to terminate those waivers effective February 16, 2026. New Governor Sherrill issued EO 13 on February 13, 2026 to extend the waiver for 45 days to April 2, 2026 to allow more time for legislative action. S2996/A4052 was signed on March 30, 2026, providing a permanent legislative solution before the EO 13 extension expired.
What S2996/A4052 Creates
The legislation makes independent practice permanent for certain APNs who provide primary or behavioral health care and who meet qualifying experience criteria. The specific experience threshold in the enacted bill is more than 5,000 hours of licensed, active advanced nursing practice. APNs who meet this threshold and practice in covered care settings are no longer required to maintain a joint protocol with a collaborating physician.
APNs who do not meet the experience threshold, or who practice outside covered primary or behavioral health care settings, continue to require a written joint protocol under the existing statutory framework.
Track 1: APNs Who Now Qualify for Independent Practice
Under S2996/A4052, APNs who meet both the experience criteria and the practice-setting criteria may practice and prescribe without a joint protocol with a collaborating physician.
Qualifying Criteria
Based on the enacted legislation and Committee Substitute bill statement, qualifying APNs must:
- Have completed more than 5,000 hours of licensed, active advanced nursing practice
- Provide primary care or behavioral health care services
What Independent Practice Means
An APN who qualifies for the S2996/A4052 exemption may prescribe medications including controlled dangerous substances without a joint protocol. The physician’s name is no longer required on the APN’s prescriptions. The chart review requirements that apply to joint protocol arrangements do not apply to independent practice.
Physicians and Voluntary Arrangements
Nothing in S2996/A4052 prevents an independent APN from entering into a voluntary collaborative arrangement with a physician for clinical, institutional, or insurance credentialing reasons. Hospitals, health systems, and managed care organizations may impose physician collaboration requirements beyond what state law mandates, even for APNs who qualify for the statutory exemption. Voluntary arrangements remain fully permissible.
Track 2: APNs Who Still Require a Joint Protocol With a Collaborating Physician
The majority of New Jersey APNs who have not yet accumulated 5,000 qualifying hours, or who practice outside covered primary or behavioral health care settings, continue to require a written joint protocol with a collaborating physician under NJSA 45:11-49 and NJAC 13:37-8.1.
Who Falls Into Track 2
Track 2 applies to all APNs who are:
- New graduates and early-career APNs who have not yet accumulated 5,000 qualifying hours
- APNs providing specialty care outside the primary or behavioral health settings covered by S2996/A4052
- APNs practicing in settings such as aesthetic medicine, pain management, hospital-based practice, or other specialty contexts where the S2996/A4052 exemption does not apply
The Track 2 joint protocol framework under NJSA 45:11-49 and NJAC 13:37-8.1 is fully operative for these APNs and carries the same substantive physician collaboration obligations that existed before the COVID waivers.
The Joint Protocol Under NJSA 45:11-49 and NJAC 13:37-8.1
Under NJSA 45:11-49, an advanced practice nurse may order medications, devices, and controlled dangerous substances only in accordance with joint protocols established in agreement with a collaborating physician or pursuant to specific physician direction.
The joint protocol is defined in NJAC 13:37-8.1 as the document that establishes the collaborative practice framework between the APN and the physician. Failure to establish and implement joint protocols consistent with these standards may be deemed professional misconduct or other grounds for disciplinary sanction by each party’s respective licensing board.
The Joint Protocol Must Be in Writing
Under NJAC 13:37-8.1, the joint protocol must be in writing and signed by both the APN and the collaborating physician.
Where the Protocol Must Be Kept
The joint protocol must be kept at each APN practice office. A single practice location requires one joint protocol at that location. An APN practicing at multiple offices must maintain the protocol at each office location.
Annual Review and Update
The joint protocol must be reviewed at least annually and updated as practice details change. An agreement that has passed the one-year mark without a documented annual review is not current.
What the New Jersey Joint Protocol Must Address
Under NJSA 45:11-49 and NJAC 13:37-8.1, the joint protocol must address all of the following:
1. Standing Orders and Prescribing Framework
The protocol must establish standing orders or the specific framework under which the APN may initiate prescriptions and orders. Prescriptions written by APNs under a joint protocol must be written in accordance with those standing orders or pursuant to specific physician direction.
2. Physician Name on Prescriptions and Orders
Under NJSA 45:11-49, the APN must print the collaborating physician’s name on every prescription and on every order for medications and devices. The APN signs the prescription with their own name and prints their own name and certification number. The collaborating physician’s name must appear on the same prescription form.
3. Controlled Dangerous Substance Prescribing Protocol
The joint protocol must specifically address whether prior consultation with the collaborating physician is required before the APN initiates an order or prescription for a controlled dangerous substance. This is not an optional provision. The joint protocol must take a defined position on this question, either requiring prior consultation for CDS prescriptions or establishing conditions under which the APN may initiate CDS prescriptions without prior consultation.
4. Medical Use of Cannabis Authorization
Under New Jersey medical cannabis laws, APNs and collaborating physicians must address in their joint protocols whether prior consultation with the collaborating physician is required before the APN authorizes a qualifying patient for the medical use of cannabis. This cannabis-specific consultation provision must be addressed in the joint protocol.
5. Physician Availability Requirement
Under NJSA 45:11-49(b)(4), the physician must be present or readily available through electronic communications at all times the APN is ordering or prescribing under the joint protocol. Readily available through electronic communications means the physician is reachable by phone, telehealth, or other electronic means when clinical questions arise. A physician who is consistently unreachable during the APN’s practice hours is not meeting the statutory availability standard.
6. Chart and Record Review Process
The joint protocol must establish a process for chart and record review as described below.
Physician Eligibility: License, Availability, and Presence Requirements
A New Jersey collaborating physician must hold a current, active New Jersey medical license. The physician must be licensed to practice medicine in New Jersey, not merely in another state.
The Presence and Availability Standard
Under NJSA 45:11-49, for an APN to order medications and devices under a joint protocol, the collaborating physician must be present or readily available through electronic communications. This standard applies at the time of ordering and prescribing. A physician who is physically present at the APN’s practice location satisfies the standard. A physician who is not physically present must be reachable by phone or electronic means at the time the APN is providing care under the protocol.
New Jersey does not impose a geographic proximity requirement but the availability standard is active and immediate. A physician who is in another state or country and is unreachable by phone during the APN’s practice session is not meeting the NJSA 45:11-49 standard.
No Ratio Limit
New Jersey does not impose a statutory cap on the number of APNs a physician may collaborate with simultaneously.
Chart and Record Review Obligations
Under NJSA 45:11-49(b)(5), the charts and records of patients treated by the APN under a joint protocol must be reviewed by the collaborating physician and the APN within the period of time specified by rules adopted by the Commissioner of Health.
What the Review Must Cover
The chart and record review must be documented. Both the physician and the APN must participate. The records reviewed, the dates of review, and any clinical guidance or corrections resulting from the review should be documented.
The Review Is a Substantive Obligation
The chart and record review is not an administrative formality. It is the primary mechanism through which the collaborating physician fulfills the ongoing oversight function the joint protocol creates. A physician who signs a joint protocol but never reviews any patient charts has not met this obligation regardless of the other terms of the agreement.
Controlled Dangerous Substance Prescribing in New Jersey
New Jersey APNs under joint protocols may prescribe controlled dangerous substances in Schedules II through V when the prescription is written in accordance with the standing orders or joint protocols established with the collaborating physician.
The Prior Consultation Question
The joint protocol must address whether prior consultation with the physician is required before the APN initiates a CDS prescription. The parties determine this in the protocol. A physician who wants to require prior consultation for all Schedule II prescriptions must include that requirement in the joint protocol. A protocol that is silent on this question creates ambiguity about whether a Schedule II prescription written without prior consultation is authorized.
Prescription Requirements
All APN prescriptions under a joint protocol must be written on a New Jersey Prescription Blank pursuant to PL 2003, c.280. The APN signs the prescription with their own name and prints their name and certification number. The collaborating physician’s name must also be printed on the prescription.
The 2025 to 2026 Regulatory Timeline: COVID Waivers, EO 415, EO 13, and S2996
New Jersey’s physician collaboration landscape experienced rapid and consequential changes between late 2025 and March 2026. Understanding this timeline is important context for any physician entering a New Jersey APN collaboration arrangement.
- March 2020: Governor Murphy declared COVID-19 State of Emergency. EO 112 suspended the joint protocol requirement, allowing APNs to prescribe without a collaborating physician for the duration of the emergency.
- Through 2025: Approximately 17,000 APNs and 4,000 PAs in New Jersey practiced under the suspended requirements.
- Late 2025: Governor Murphy issued EO 415, terminating the COVID waivers effective February 16, 2026 and reinstating the pre-pandemic joint protocol requirement.
- February 13, 2026: Governor Sherrill signed EO 13, extending the waiver for 45 days to April 2, 2026.
- March 30, 2026: Governor Sherrill signed S2996/A4052, creating permanent independent practice for qualifying APNs and preserving the joint protocol requirement for non-qualifying APNs.
For APNs Who Practiced Without Joint Protocols Since 2020
APNs who have been practicing since 2020 under COVID waivers and who do not qualify for the S2996/A4052 exemption must now have a written, signed joint protocol in place. Any APN who is non-exempt and practicing without a current joint protocol as of the S2996 effective date is practicing outside the legal framework.
PA Requirements in New Jersey: The Delegation Agreement
Physician assistants in New Jersey are not covered by the APN joint protocol framework. PAs must have a separate delegation agreement with a supervising physician under New Jersey PA law and regulations.
The Delegation Agreement
PAs in New Jersey must have a signed delegation agreement with a supervising physician that defines the scope of the PA’s practice and prescribing authority. Under New Jersey law, PAs must be under continuous physician supervision, either in person or through electronic communication.
The COVID Waiver Impact on PAs
The COVID waivers that suspended joint protocol requirements for APNs also affected PA supervision requirements. EO 415 and the subsequent EO 13 extension applied to both APNs and PAs. New Jersey practices employing PAs must ensure delegation agreements are in place with supervising physicians following the reinstatement of pre-pandemic requirements.
Common Compliance Mistakes New Jersey Collaborating Physicians Make
Most New Jersey joint protocol compliance problems involve protocol content gaps, the physician name requirement on prescriptions, and failure to conduct documented chart reviews.
- Protocol does not address controlled dangerous substance consultation. The joint protocol must explicitly state whether prior physician consultation is required before the APN initiates a CDS prescription. A protocol that is silent on this question is incomplete and creates ambiguity about the APN’s CDS prescribing authority.
- Protocol does not address cannabis authorization consultation. New Jersey cannabis law requires the joint protocol to address whether prior physician consultation is required before the APN authorizes a patient for medical cannabis. This cannabis-specific provision is mandatory and distinct from the CDS consultation provision.
- Physician name not printed on APN prescriptions. Every prescription and order written by a Track 2 APN must include the collaborating physician’s printed name. A prescription bearing only the APN’s name without the physician’s name does not satisfy NJSA 45:11-49.
- Protocol not kept at each practice location. The joint protocol must be maintained at each APN practice office where the APN sees patients. A protocol kept at the main office does not cover a satellite location.
- Annual review not documented. The protocol must be reviewed at least annually. A protocol that has passed a year without a documented review is not current even if the clinical content remains accurate.
- Physician not genuinely available when APN is prescribing. NJSA 45:11-49 requires the physician to be present or readily available through electronic communications when the APN is ordering medications and devices. A physician who is frequently unreachable during the APN’s practice hours is not meeting this requirement.
New Jersey Collaborating Physician Requirements: Quick Reference
Practice Authority Framework (Post-S2996/A4052, Effective March 30, 2026)
- Track 1 (Independent Practice): APNs with more than 5,000 hours of licensed active advanced nursing practice providing primary or behavioral health care; no joint protocol required
- Track 2 (Joint Protocol Required): APNs without qualifying hours or outside covered care settings; written joint protocol with a collaborating physician required
Joint Protocol Requirements (Track 2 APNs)
- Written and signed by both parties
- Kept at each APN practice office
- Reviewed at least annually; updated as practice details change
- Must address: standing orders, physician name on prescriptions, CDS consultation requirement, medical cannabis consultation requirement, physician availability, chart review process
Physician Availability Standard
- Physician must be present or readily available through electronic communications when APN is ordering or prescribing
- No geographic proximity requirement; active availability required
Chart Review
- Charts and records reviewed by both physician and APN within timeframe specified by Commissioner of Health rules
- Review must be documented
Prescription Requirements
- APN signs own name; prints own name and certification number; prints collaborating physician’s name
PA Requirements
- Delegation agreement with supervising physician required
- Continuous supervision in person or by electronic communication required
Clinics Also Need to Understand New Jersey Collaboration Requirements
While this guide primarily covers the physician collaboration requirements in New Jersey, these regulations directly affect APN-operated clinics, specialty practices, medspas, and healthcare organizations that depend on physician collaboration for Track 2 APNs. The 2026 dual-track system requires every clinic in New Jersey to assess whether each APN meets the S2996/A4052 exemption criteria and to ensure compliant joint protocols are in place for all non-exempt APNs.
Need Help Finding a New Jersey Collaborating Physician?
For clinics whose APNs remain in Track 2, the next challenge is finding a qualified New Jersey-licensed physician who is ready to execute a compliant written joint protocol covering all required elements, will be genuinely available by electronic communications during APN practice hours, and will fulfill the chart and record review obligations the protocol creates. Whether you are launching a new clinic with a Track 2 APN, building joint protocols for an existing practice following the end of COVID waivers, or managing the transition as your APNs accumulate hours toward the Track 1 threshold, having the right physician in place is essential.
If your clinic is actively looking for a New Jersey collaborating physician, our team can match you with a qualified physician, often within 24 to 48 hours. We work with clinics across New Jersey to simplify the physician matching process while supporting joint protocol drafting, annual review tracking, and long-term collaboration needs.
Final Thoughts
New Jersey collaborating physician requirements are in a new phase. The COVID waivers are over. S2996/A4052 has permanently restructured APRN practice into a dual-track system. For Track 2 APNs, the joint protocol requirements under NJSA 45:11-49 and NJAC 13:37-8.1 are fully reinstated and fully operative. For Track 1 APNs, independent practice is now a permanent statutory right. For physicians in New Jersey, the most important steps are confirming which track each APN falls into, ensuring joint protocols are written, complete, kept at each practice location, and include all required provisions, and providing genuine availability during APN practice hours.
Build a Compliant New Jersey Collaboration With Collaborating Physician
Are you looking for a collaborating physician role in New Jersey? If you are a licensed New Jersey physician interested in a structured, compliant joint protocol arrangement with an APN clinic, Collaborating Physician handles the infrastructure so you do not have to figure it out alone. The platform connects licensed physicians with vetted clinics across New Jersey and 50-plus other states. Every arrangement is built to meet state-specific requirements, including New Jersey’s joint protocol standards under NJSA 45:11-49 and NJAC 13:37-8.1, the S2996/A4052 dual-track framework, controlled dangerous substance consultation provisions, medical cannabis authorization requirements, physician name requirements on prescriptions, and chart review obligations. Physicians receive compliance support throughout the collaboration, not just at the start. Applications take under ten minutes. Clinic matches typically happen within 24 to 48 hours. There is no cost to physicians at any stage.
If you are a clinic owner who found this page, we have something for you as well. Collaborating Physician also matches New Jersey clinics with qualified, vetted collaborating physicians who hold active New Jersey medical licenses, understand the S2996/A4052 dual-track framework, and are prepared to execute complete joint protocols covering all required provisions. Whether you are launching a new APN clinic under Track 2, building joint protocols post-COVID-waiver, or assessing which of your APNs qualify for Track 1 independent practice, the network is active and placements happen within 24 to 48 hours. For clinics looking for a collaborating physician, get matched fast.
Disclaimer: This content is for educational and informational purposes only. It does not constitute legal or medical advice. New Jersey healthcare regulations changed significantly in early 2026. Always verify current requirements directly with the New Jersey Board of Nursing, the New Jersey State Board of Medical Examiners, and a qualified New Jersey healthcare attorney before making any practice decisions.
Frequently Asked Questions
Does a New Jersey APN need a collaborating physician after S2996/A4052?
It depends on which track the APN falls into. APNs who have completed more than 5,000 hours of licensed, active advanced nursing practice and who provide primary or behavioral health care qualify for independent practice under S2996/A4052 and do not need a joint protocol. APNs who do not meet these criteria still require a written joint protocol with a collaborating New Jersey-licensed physician.
What happened to the COVID-era waivers in New Jersey?
The COVID-era waivers that suspended joint protocol requirements were terminated. Former Governor Murphy issued EO 415 to end them effective February 16, 2026. Governor Sherrill extended the waiver 45 days to April 2, 2026 via EO 13. S2996/A4052, signed March 30, 2026, provided the permanent legislative solution by creating the dual-track framework described in this guide.
What must a New Jersey joint protocol contain?
Under NJSA 45:11-49 and NJAC 13:37-8.1, a joint protocol must be in writing, signed, kept at each APN practice office, and reviewed at least annually. It must address standing orders for prescribing, whether prior physician consultation is required before CDS prescriptions, whether prior consultation is required before cannabis authorizations, physician availability, and chart review processes.
Does the collaborating physician’s name need to appear on APN prescriptions in New Jersey?
Yes. Under NJSA 45:11-49, every prescription written by a Track 2 APN must include the collaborating physician’s printed name in addition to the APN’s signature, name, and certification number.
How often must a New Jersey joint protocol be reviewed?
Under NJAC 13:37-8.1, the joint protocol must be reviewed at least annually and updated whenever practice details change. An agreement that has passed one year without a documented review is not current.
What are the PA requirements in New Jersey?
PAs in New Jersey must have a signed delegation agreement with a supervising physician defining their scope of practice and prescribing authority. PAs must also be under continuous physician supervision, either in person or through electronic communication. These requirements apply separately from the APN joint protocol framework.
